To investigate the pre-clinical relevance of active FAK and EZH2-mediated signaling in vivo, we performed IHC analysis to detect the protein levels of p-FAK, EZH2, and its corresponding substrate, H3K27me3, in lung-cancer-cells-derived tumor tissue arrays. The gene discussed is EZH2; the disease is lung cancer.